Fang W H, Yao Y M, Shi Z G, Yu Y, Wu Y, Lu L R, Sheng Z Y
Department of Microbiology and Immunology, Trauma Research Center, Postgraduate Medical College, 304th Hospital, Beijing, People's Republic of China.
Crit Care Med. 2001 Jul;29(7):1452-9. doi: 10.1097/00003246-200107000-00025.
To investigate the potential mechanisms underlying the in vivo effect of recombinant bactericidal/permeability-increasing protein (rBPI21) on endogenous bacteria or endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression secondary to thermal injury.
Prospective, randomized, controlled animal study.
College hospital animal research laboratory.
Thirty-six male Wistar rats weighing 250-300 g.
The rats were anesthetized, and a 35% total body surface area full-thickness burn was created. Animals were randomized to receive treatment with either rBPI21 or the control protein (albumin). rBPI21 (2 mg/kg body wt, BPI group) or a protein control preparation (burn group) in the same dose was administered in an intravenous bolus at 30 mins and 4 hrs after thermal injury. All animals were killed at 12 and 24 hrs postburn (six to ten rats for each interval). In addition, eight rats were taken as normal controls.
Our data showed that treatment with rBPI21 was effective in preventing endotoxin translocation secondary to severe burns. Meanwhile, tissue lipopolysaccharide-binding protein, CD14, and tumor necrosis factor-alpha mRNA expression in various organs were inhibited markedly by rBPI21 secondary to acute insults (p <.05-.01). Furthermore, significant reduction in serum aminoleucine transferase concentrations and elevation in intestinal diamine oxidase activities in the rBPI21-treated group were found compared with controls (p <.05-.01).
These findings indicate that endotoxin accumulated in local sites after thermal injury can markedly up-regulate lipopolysaccharide-binding protein/CD14 and tumor necrosis factor-alpha mRNA expression in various organs. Meanwhile, up-regulation of lipopolysaccharide-binding protein/CD14 expression would be the major molecular mechanism of increasing sensitivity to endogenous endotoxin response after burns. Early treatment with rBPI21may be effective in attenuating multiple organ damage resulting from gut-origin endotoxin translocation. This might be associated with the down-regulation effects of tissue lipopolysaccharide-binding protein and CD14 gene expression by the use of rBPI21.
探讨重组杀菌/通透性增加蛋白(rBPI21)对热损伤后内源性细菌或内毒素移位以及脂多糖结合蛋白/CD14表达的体内作用潜在机制。
前瞻性、随机、对照动物研究。
大学医院动物研究实验室。
36只体重250 - 300克的雄性Wistar大鼠。
大鼠麻醉后,造成35%体表面积的全层烧伤。动物被随机分为接受rBPI21或对照蛋白(白蛋白)治疗。在热损伤后30分钟和4小时静脉推注给予rBPI21(2毫克/千克体重,BPI组)或相同剂量的蛋白对照制剂(烧伤组)。所有动物在烧伤后12小时和24小时处死(每个时间段6至10只大鼠)。此外,8只大鼠作为正常对照。
我们的数据表明,rBPI21治疗可有效预防严重烧伤后的内毒素移位。同时,rBPI21可显著抑制急性损伤后各器官组织中脂多糖结合蛋白、CD14和肿瘤坏死因子-α mRNA的表达(p <.05 -.01)。此外,与对照组相比,rBPI21治疗组血清氨基转移酶浓度显著降低,肠二胺氧化酶活性升高(p <.05 -.01)。
这些发现表明,热损伤后局部积聚的内毒素可显著上调各器官中脂多糖结合蛋白/CD14和肿瘤坏死因子-α mRNA的表达。同时,脂多糖结合蛋白/CD14表达上调将是烧伤后对内源性内毒素反应敏感性增加的主要分子机制。早期使用rBPI21治疗可能有效减轻肠道源性内毒素移位导致的多器官损伤。这可能与rBPI21下调组织脂多糖结合蛋白和CD14基因表达的作用有关。